SE9004010L - - Google Patents

Info

Publication number
SE9004010L
SE9004010L SE9004010A SE9004010A SE9004010L SE 9004010 L SE9004010 L SE 9004010L SE 9004010 A SE9004010 A SE 9004010A SE 9004010 A SE9004010 A SE 9004010A SE 9004010 L SE9004010 L SE 9004010L
Authority
SE
Sweden
Application number
SE9004010A
Other languages
Swedish (sv)
Other versions
SE9004010D0 (sv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898928562A external-priority patent/GB8928562D0/en
Priority claimed from GB909004414A external-priority patent/GB9004414D0/en
Priority claimed from GB909004814A external-priority patent/GB9004814D0/en
Application filed filed Critical
Publication of SE9004010D0 publication Critical patent/SE9004010D0/xx
Publication of SE9004010L publication Critical patent/SE9004010L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE9004010A 1989-12-18 1990-12-17 Viralt medel SE9004010D0 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB898928562A GB8928562D0 (en) 1989-12-18 1989-12-18 Viral agent
GB909004414A GB9004414D0 (en) 1990-02-27 1990-02-27 Viral agent
GB909004814A GB9004814D0 (en) 1990-03-03 1990-03-03 Viral agent

Publications (2)

Publication Number Publication Date
SE9004010D0 SE9004010D0 (sv) 1990-12-17
SE9004010L true SE9004010L (cg-RX-API-DMAC7.html) 1991-06-19

Family

ID=27264852

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9004010A SE9004010D0 (sv) 1989-12-18 1990-12-17 Viralt medel

Country Status (24)

Country Link
US (1) US6210675B1 (cg-RX-API-DMAC7.html)
JP (1) JPH06107687A (cg-RX-API-DMAC7.html)
AR (1) AR243239A1 (cg-RX-API-DMAC7.html)
AT (1) AT400724B (cg-RX-API-DMAC7.html)
AU (1) AU642942B2 (cg-RX-API-DMAC7.html)
BE (1) BE1005485A5 (cg-RX-API-DMAC7.html)
BR (1) BR9006422A (cg-RX-API-DMAC7.html)
CA (1) CA2032381C (cg-RX-API-DMAC7.html)
CH (1) CH684594A5 (cg-RX-API-DMAC7.html)
DE (1) DE4040339C2 (cg-RX-API-DMAC7.html)
DK (1) DK298190A (cg-RX-API-DMAC7.html)
ES (1) ES2029171A6 (cg-RX-API-DMAC7.html)
FI (1) FI906208L (cg-RX-API-DMAC7.html)
FR (1) FR2655990A1 (cg-RX-API-DMAC7.html)
GB (1) GB2239245B (cg-RX-API-DMAC7.html)
GR (1) GR1001261B (cg-RX-API-DMAC7.html)
HU (1) HUT56883A (cg-RX-API-DMAC7.html)
IE (1) IE65172B1 (cg-RX-API-DMAC7.html)
IT (1) IT1242183B (cg-RX-API-DMAC7.html)
LU (1) LU87861A1 (cg-RX-API-DMAC7.html)
NL (1) NL9002779A (cg-RX-API-DMAC7.html)
NO (1) NO905438L (cg-RX-API-DMAC7.html)
NZ (1) NZ236491A (cg-RX-API-DMAC7.html)
SE (1) SE9004010D0 (cg-RX-API-DMAC7.html)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US5712088A (en) * 1987-11-18 1998-01-27 Chiron Corporation Methods for detecting Hepatitis C virus using polynucleotides specific for same
US5714596A (en) * 1987-11-18 1998-02-03 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
US5698390A (en) * 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US6861212B1 (en) 1987-11-18 2005-03-01 Chiron Corporation NANBV diagnostics and vaccines
US6027729A (en) * 1989-04-20 2000-02-22 Chiron Corporation NANBV Diagnostics and vaccines
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
US5712087A (en) * 1990-04-04 1998-01-27 Chiron Corporation Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
RO109916B1 (ro) * 1990-04-04 1995-07-28 Chiron Corp Compozitie de antigeni ai hepatitei virale c
WO1991015516A2 (en) * 1990-04-06 1991-10-17 Genelabs Incorporated Hepatitis c virus epitopes
JP3549201B2 (ja) * 1990-10-24 2004-08-04 中外製薬株式会社 非ａ非ｂ型肝炎特異的遺伝子の検出方法及び検出用試薬組成物
EP0485209A1 (en) * 1990-11-08 1992-05-13 Immuno Japan Inc. Non A, non B hepatitis virus related antigen, antibody detection systems, polynucleotides and polypeptides
KR920703640A (ko) * 1990-11-29 1992-12-18 테루카츄 아리마 비a비b형 간염 바이러스 항원 단백질
PL170151B1 (pl) * 1991-05-08 1996-10-31 Chiron Corp Sposób wykrywania jednego lub wiecej genotypów wirusa zapalenia watroby C PL PL PL
US6190864B1 (en) 1991-05-08 2001-02-20 Chiron Corporation HCV genomic sequences for diagnostics and therapeutics
ATE229543T1 (de) * 1991-06-24 2002-12-15 Chiron Corp Polypeptide des hepatitis c-virus (hiv)
WO1993002193A1 (es) * 1991-07-19 1993-02-04 Bartolome Nebreda Fernando Jav cDNAS DERIVADOS DEL VIRUS C DE LA HEPATITIS
DE69233083T2 (de) * 1991-08-27 2003-12-18 F. Hoffmann-La Roche Ag, Basel Primers und Sondern zum Nachweis von Hepatitis C
GB9203803D0 (en) * 1992-02-21 1992-04-08 Wellcome Found A recombinant polypeptide
UA39944C2 (uk) * 1992-07-07 2001-07-16 Чірон Корпорейшн Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
US6153378A (en) * 1992-10-16 2000-11-28 Bionova Corporation Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
CA2662090A1 (en) 1993-04-27 1994-11-10 N.V. Innogenetics S.A. New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
US7255997B1 (en) 1993-04-27 2007-08-14 N.V. Innogenetics S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
US5885771A (en) * 1993-10-29 1999-03-23 Srl, Inc. Antigenic peptide compound and immunoassay
EP1076092A3 (en) 1994-10-21 2001-03-28 Innogenetics N.V. Sequences of hepatitis C virus type10 and their use as prophylactic, therapeutic and diagnostic agents
FR2775690B1 (fr) * 1998-03-09 2001-12-14 Bio Merieux Anticorps monoclonal et utilisations pour detecter des antigenes de la proteine core de vhc
US6071721A (en) * 1998-11-13 2000-06-06 Incyte Pharmaceuticals, Inc. Calcium binding protein
US7067313B1 (en) * 1999-07-14 2006-06-27 D. Collen Research Foundation Ligands for use in therapeutic compositions for the treatment of hemostasis disorders
US7829085B2 (en) 1999-07-14 2010-11-09 Life Sciences Research Partners Vzw Methods of treating hemostasis disorders using antibodies binding the C1 domain of factor VIII
CU23244A1 (es) * 2001-07-16 2007-10-17 Ct Ingenieria Genetica Biotech Formulacion vacunal potenciada por la combinacion de un adn con un antigeno
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
ATE410693T1 (de) * 2002-09-09 2008-10-15 Novartis Vaccines & Diagnostic Hcv-test
JP4422430B2 (ja) * 2003-05-14 2010-02-24 帝國製薬株式会社 エストロゲン及び／又はプロゲストゲン含有外用貼付剤
ES2412489T3 (es) * 2003-08-14 2013-07-11 Thrombogenics N.V. Anticuerpos contra el factor VIII con glucosilación modificada en la región variable
US8124747B2 (en) 2003-08-29 2012-02-28 Innogenetics HCV clade and prototype sequences thereof
ES2702278T3 (es) 2012-04-01 2019-02-28 Technion Res & Dev Foundation Péptidos de inductor de metaloproteinasa de matriz extracelular (emmprin) y anticuerpos de unión
WO2019144052A1 (en) * 2018-01-18 2019-07-25 Adanate, Inc. Anti-lilrb antibodies and uses thereof

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356164A (en) 1979-05-21 1982-10-26 Govt. of the U.S., as represented by the Secretary, Dept. of Health & Human Services Detection of non-A, non-B hepatitis associated antigen
US4464474A (en) * 1980-07-09 1984-08-07 Connaught Laboratories Limited Non-A, non-B hepatitis assay and vaccine
CA1168579A (en) 1981-02-11 1984-06-05 Philippe Maupas (Deceased) Non-a, non-b hepatitis virus
US4542016A (en) 1981-03-27 1985-09-17 Institut Merieux Non-a non-b hepatitis surface antigen useful for the preparation of vaccines and methods of use
JPS57198867A (en) 1981-06-02 1982-12-06 Eisai Co Ltd Non-a, non-b hepatitis related antigen and diagnostic therefor
JPS58183629A (ja) 1982-04-21 1983-10-26 Eisai Co Ltd 非ａ非ｂ型肝炎関連モノクロナ−ル抗体および診断薬
US4702909A (en) * 1982-05-05 1987-10-27 Louisiana State University A & M Non-A, non-B hepatitis antigen, antigen compositions, vaccine and diagnostic reagent
US4707439A (en) 1984-10-26 1987-11-17 The United States Of America As Represented By The Department Of Health And Human Services Screening test for reverse-transcriptase containing virus such as non-A, non-B hepatitis, NANBH
GB8431171D0 (en) 1984-12-11 1985-01-23 Technology Licence Co Ltd Monoclonal antibodies
JPS61176856A (ja) 1985-02-01 1986-08-08 Mitsubishi Chem Ind Ltd 非ａ非ｂ型肝炎抗原
US4673634A (en) 1985-03-08 1987-06-16 The United States Of America As Represented By The Department Of Health And Human Services Purified antigen from non-A, non-B hepatitis causing factor
FR2597606B1 (fr) 1986-04-16 1989-10-06 Pasteur Institut Nouveau reactif pour la detection d'hepatites virales non a non b et procede de diagnostic de telles hepatites par voie immunoenzymatique
JPS6391328A (ja) 1986-10-07 1988-04-22 Mitsubishi Kasei Corp 非ａ非ｂ型肝炎抗原
NZ222465A (en) 1986-11-07 1992-11-25 Pasteur Institut Nanb (non a, non b hepatitis viral) antigen
US5141867A (en) * 1987-02-02 1992-08-25 E. I. Du Pont De Nemours And Company Nucleotide sequence encoding a human immunodeficiency virus antigen
DE3744242A1 (de) 1987-02-20 1989-07-06 Seelig Renate Virusantigen, verfahren zu seiner gewinnung und anwendung in diagnose und therapie (impfstoff)
US5032511A (en) * 1987-03-31 1991-07-16 Mitsubishi Kasei Corporation DNA fragments coding for antigens specific to non-A non-B hepatitis, expression vectors containing said DNA fragments, transformants and process for producing said antigens
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
AU624105B2 (en) * 1987-11-18 1992-06-04 Novartis Vaccines And Diagnostics, Inc. Nanbv diagnostics and vaccines
YU48038B (sh) * 1987-11-18 1996-10-18 Chiron Corp. Postupak za dijagnostiku ne-a, ne-v hepatitisa
DE318216T1 (de) * 1987-11-18 1990-06-13 Chiron Corp., Emeryville, Calif. Nanbv-diagnostika und vakzine.
AU632271B2 (en) 1988-03-30 1992-12-24 Abbott Laboratories Production of monoclonal antibodies specific for non-a, non-b hepatitis infected liver
AU3748489A (en) 1988-06-17 1990-01-12 Genelabs Incorporated Enterically transmitted non-a/non-b hepatitis viral agent
WO1990000597A1 (en) * 1988-07-06 1990-01-25 Genelabs Incorporated Post-transfusion, non-a, non-b hepatitis virus and antigens
IL91371A0 (en) 1988-08-24 1990-04-29 Us Commerce Clones or vectors bearing dna sequences of non-a and non-b hepatitis and a method for detecting these materials in blood
US5191064A (en) * 1988-09-30 1993-03-02 The Research Foundation For Microbial Diseases (Osaka University) Non-a, non-b hepatitis virus antigen peptide
JPH02167081A (ja) 1988-12-21 1990-06-27 Tetsuo Nakamura 非Ａ非Ｂ型肝炎ウイルスゲノムＲＮＡ、ｃＤＮＡおよびウイルス抗原蛋白質
HU225068B1 (en) * 1989-03-17 2006-05-29 Chiron Corp Process for producing diagnostics and vaccine of nanbh
HUT59964A (en) * 1989-05-18 1992-07-28 Chiron Corp Process for producing new nanbv diagnostica for determining hepatitis c virus
EP0416725A3 (en) * 1989-07-14 1991-03-20 Chugai Seiyaku Kabushiki Kaisha Blood-borne non-a, non-b hepatitis specific protein, dna encoding it, and process for its production
ES2110411T3 (es) 1989-08-25 1998-02-16 Chiron Corp Metodos para cultivar el virus de la hepatitis c (hcv) en lineas celulares de linfocitos b o t.
WO1991004262A1 (en) 1989-09-15 1991-04-04 National Institute Of Health Of Japan New hcv isolates
US5372928A (en) 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
RO109916B1 (ro) 1990-04-04 1995-07-28 Chiron Corp Compozitie de antigeni ai hepatitei virale c
EP0933426A1 (en) * 1990-06-25 1999-08-04 The Research Foundation for Microbial Diseases of Osaka University Non-a, non-b hepatitis virus genomic cdna fragments and antigen polypeptides

Also Published As

Publication number Publication date
DE4040339C2 (de) 1999-07-08
US6210675B1 (en) 2001-04-03
GB2239245B (en) 1993-11-10
NO905438L (no) 1991-06-19
AU6817590A (en) 1991-06-20
SE9004010D0 (sv) 1990-12-17
IT9048588A0 (it) 1990-12-17
NL9002779A (nl) 1991-07-16
NZ236491A (en) 1993-10-26
IT9048588A1 (it) 1991-06-19
FR2655990B1 (cg-RX-API-DMAC7.html) 1995-04-07
ES2029171A6 (es) 1992-07-16
FI906208A7 (fi) 1991-06-19
HU908296D0 (en) 1991-06-28
IE65172B1 (en) 1995-10-04
GB2239245A (en) 1991-06-26
AT400724B (de) 1996-03-25
BR9006422A (pt) 1991-09-24
LU87861A1 (fr) 1991-10-08
GB9027250D0 (en) 1991-02-06
CA2032381A1 (en) 1991-06-19
BE1005485A5 (fr) 1993-08-10
FI906208A0 (fi) 1990-12-17
CH684594A5 (fr) 1994-10-31
AR243239A1 (es) 1993-07-30
FI906208L (fi) 1991-06-19
AU642942B2 (en) 1993-11-04
NO905438D0 (no) 1990-12-17
GR900100868A (en) 1992-05-12
FR2655990A1 (fr) 1991-06-21
IT1242183B (it) 1994-02-16
DK298190D0 (da) 1990-12-17
JPH06107687A (ja) 1994-04-19
GR1001261B (el) 1993-06-30
ATA257190A (de) 1995-07-15
IE904540A1 (en) 1991-06-19
HUT56883A (en) 1991-10-28
DK298190A (da) 1991-06-19
DE4040339A1 (de) 1991-06-20
CA2032381C (en) 2006-02-21

Similar Documents

Publication Publication Date Title
FR2655990B1 (cg-RX-API-DMAC7.html)
DE4091597T (cg-RX-API-DMAC7.html)
DE4091841T (cg-RX-API-DMAC7.html)
DE4092105T (cg-RX-API-DMAC7.html)
DE4090663T (cg-RX-API-DMAC7.html)
FR2641750B1 (cg-RX-API-DMAC7.html)
FR2642974B1 (cg-RX-API-DMAC7.html)
DE4090165T (cg-RX-API-DMAC7.html)
FR2645234B1 (cg-RX-API-DMAC7.html)
FR2641722B1 (cg-RX-API-DMAC7.html)
DE3991793T1 (cg-RX-API-DMAC7.html)
DE4090770T (cg-RX-API-DMAC7.html)
DE3991752T (cg-RX-API-DMAC7.html)
DE4092109T (cg-RX-API-DMAC7.html)
FR2643671B1 (cg-RX-API-DMAC7.html)
FR2644952B1 (cg-RX-API-DMAC7.html)
FR2642552B1 (cg-RX-API-DMAC7.html)
DE4090739T (cg-RX-API-DMAC7.html)
DE4091752T (cg-RX-API-DMAC7.html)
FR2644164B1 (cg-RX-API-DMAC7.html)
DE4042389A1 (cg-RX-API-DMAC7.html)
DE4090078T (cg-RX-API-DMAC7.html)
EP0668703A3 (cg-RX-API-DMAC7.html)
DE4091054T (cg-RX-API-DMAC7.html)
FR2644734B1 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9004010-6